Tectonic Therapeutic | AVRO - Interest Expense On Debt

Stock Price
22.94
Daily Change
0.42 1.87%
Monthly
16.39%
Yearly
-52.22%
Q1 Forecast
19.37

Tectonic Therapeutic reported $277M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Alnylam Pharmaceuticals USD 44.4M 4.15M Sep/2025
Celltrion KRW 19B 1.96B Jun/2025
Cspc Pharmaceutical CNY 10.19M 4.73M Sep/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 30M 20M Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 2.37M 6K Sep/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
MacroGenics USD 3.34M 2.54M Sep/2025
Medical Developments International AUD 18K 3K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Pfizer USD 652M 2M Sep/2025
Pharma Mar EUR 117K 1.24M Sep/2025
Qiagen NV USD 8.22M 615K Sep/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
Sarepta Therapeutics USD 7.56M 2.33M Sep/2025
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Takeda JPY 123.63B 40.49B Dec/2025
Tilray USD 6.7M 2.73M Jun/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025